ClearBridge LLC (Maryland)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-213,936
| Closed | -$18.3M | – | 186 |
|
|
2017
Q4 | $18.3M | Buy |
213,936
+20,262
| +10% | +$1.73M | 0.38% | 71 |
|
|
2017
Q3 | $16.5M | Sell |
193,674
-25,328
| -12% | -$2.15M | 0.36% | 73 |
|
|
2017
Q2 | $16.6M | Buy |
219,002
+20,254
| +10% | +$1.53M | 0.35% | 67 |
|
|
2017
Q1 | $13.1M | Buy |
198,748
+68,817
| +53% | +$4.54M | 0.28% | 74 |
|
|
2016
Q4 | $8.24M | Buy |
129,931
+23,676
| +22% | +$1.5M | 0.19% | 114 |
|
|
2016
Q3 | $6.77M | Hold |
106,255
| – | – | 0.13% | 110 |
|
|
2016
Q2 | $7.91M | Buy |
106,255
+5,178
| +5% | +$385K | 0.16% | 90 |
|
|
2016
Q1 | $6.75M | Sell |
101,077
-217
| -0.2% | -$14.5K | 0.13% | 102 |
|
|
2015
Q4 | $6.85M | Buy |
101,294
+3,687
| +4% | +$249K | 0.13% | 99 |
|
|
2015
Q3 | $5.22M | Buy |
97,607
+9,971
| +11% | +$533K | 0.11% | 111 |
|
|
2015
Q2 | $5.52M | Buy |
+87,636
| New | +$5.52M | 0.1% | 107 |
|